quinazolines has been researched along with Deep Vein Thrombosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adewoye, AH; Desai, J; Johnson, J; Kotasek, D; McCoy, S; Price, T; Siu, LL; Sun, YN; Tebbutt, N; Welch, S | 1 |
Hong, D; Kurzrock, R; Munoz, J | 1 |
Brink, JS; Brown, AK; Moir, C; Palmer, BA; Rodeberg, DR | 1 |
Di Todaro, F; Gaudenzi, P; Manfredini, R; Morandi, P; Nielsen, I; Salmi, R | 1 |
1 review(s) available for quinazolines and Deep Vein Thrombosis
Article | Year |
---|---|
Portal vein thrombosis after laparoscopy-assisted splenectomy and cholecystectomy.
Topics: Anemia, Hemolytic, Autoimmune; Anticoagulants; Child; Cholecystectomy, Laparoscopic; Cholelithiasis; Drug Therapy, Combination; Female; Humans; Hypersplenism; Laparoscopy; Portal Vein; Postoperative Complications; Quinazolines; Splenectomy; Splenic Vein; Venous Thrombosis; Warfarin | 2003 |
1 trial(s) available for quinazolines and Deep Vein Thrombosis
Article | Year |
---|---|
Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cohort Studies; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Erlotinib Hydrochloride; Female; Gemcitabine; Humans; Hypertension; Indoles; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Neoplasms; Niacinamide; Oligonucleotides; Quinazolines; Treatment Outcome; Venous Thrombosis; Vomiting; Young Adult | 2011 |
2 other study(ies) available for quinazolines and Deep Vein Thrombosis
Article | Year |
---|---|
Anticoagulation-induced severe bleeding in a patient receiving bevacizumab therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Cetuximab; Drug Eruptions; Drug Interactions; Erlotinib Hydrochloride; Female; Gastrointestinal Hemorrhage; Hematoma; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Neoplasm Staging; Quinazolines; Severity of Illness Index; Venous Thrombosis | 2012 |
Massive thrombosis of brachiocephalic veins and superior vena cava syndrome in a patient with non-small cell lung cancer treated with the epidermal growth factor receptor inhibitor erlotinib.
Topics: Antineoplastic Agents; Brachiocephalic Veins; Carcinoma, Non-Small-Cell Lung; Cyanosis; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Quinazolines; Superior Vena Cava Syndrome; Syncope; Tomography, X-Ray Computed; Venous Thrombosis | 2007 |